Wirk, Baldeep, and Jin Lim. “Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma”. Journal of Hematology 14, no. 3 (June 5, 2025): 146–151. Accessed June 17, 2025. https://jh.elmerpub.com/jh/article/view/2046.